Over halfway in the recruitment of Picasso
An important milestone is reached in the Picasso study, which is the largest of its kind. Over 200 participants are now included - and with that the project is well over halfway in goal with the inclusion. The study compares different treatments in painful osteoarthritis in the root of the thumb.
- This is a very good news. We have gained good speed in the recruitment and see that the collaboration between the hospitals works well, says project manager Ida K. Bos-Haugen, chief physician at Diakonhjemmet Hospital.
Three treatments
The Picasso study is a randomized controlled multi-center study in which researchers examine the effect of three different treatments for osteoarthritis in the root of the thumb: cortisone injection, saltwater injection (placebo) and a targeted occupational therapy offer.
A total of 354 people will be included, and the first 200 are now included.
- We would like to thank both the participants and everyone who contributes with recruitment and implementation. There is a great deal of work behind these figures, says Marthe Gløersen, doctor and postdoctoral fellow at Diakonhjemmet Hospital.
Six hospitals participate
The study is led from Remedy - research center for musculoskeletal health at Diakonhjemmet Hospital, but also recruits participants from:
- Martina Hansen's Hospital
- Haugesund Sanitetsforening Rheumatism Hospital
- Stavanger University Hospital
- St. Olavs Hospital
- Nordland Hospital in Bodø
-This is one of the biggest treatment studies on osteoarthritis in Norway, and we hope the results will benefit both patients and clinicians, says Bos-Haugen.
The Picasso study is open to people with pain in the root of the thumb who have not recently received injection treatment. The treatment takes place after a draw, and the participants are followed up closely for 6 months and with a final control after 2 years.
Want to know more?
Read more about Picasso on our website!
